Menu Back to DIA-Singapore-2019

Overview

Organized by DIA and CoRE

Scientific breakthroughs, growing amounts of healthcare data and globalization hold great promises for better health outcomes for patients in need.

Data analytics, real-world evidence, remote clinical monitoring, connected health records, electronic labeling and mobile health apps are among some of the trending topics that will shape the healthcare landscape in the coming years.

Alongside the advances in scientific understanding and health product development overall, paradigm shifts in regulatory processes and global convergence are important for greater synergy among all to bring forth timely innovation benefits to patients and consumers and patients that will improve health outcomes.

Who should attend?

  • Industry professionals involved in Research & Development, Regulatory Affairs and Medical Affairs in Pharmaceuticals and Medical Technology
  • Regulators and personnel from Health Authorities and Ministries
  • Academia and Researchers

Program Committee

  • Dorothee  Grimald, PharmD
    Dorothee Grimald, PharmD Director, Global Regulatory Policy
    MSD International GmbH, Singapore
  • James  Leong, PhD, MPharm
    James Leong, PhD, MPharm Head of Education, Centre of Regulatory Excellence, Graduate Medical School
    Duke NUS, Singapore
  • Jui-Fen  Liu, MSc, RPh
    Jui-Fen Liu, MSc, RPh APAC Regional Regulatory Policy Lead
    Roche Singapore Pte Ltd, Singapore
  • Mei  Ding
    Mei Ding JAPAC Regional Lead, Policy & Intelligence
    Abbvie Pte. Ltd., Singapore
  • Khairul Faizi  Khalid, MD
    Khairul Faizi Khalid, MD Head of Business Development
    Clinical Research Malaysia, Malaysia
  • Thean Soo  Lo
    Thean Soo Lo Director, Asia Pacific Regulatory Policy Lead, Global Regulatory Affairs
    Janssen-Cilag J&J Asia Pacific, Singapore
  • Helmi  Zakariah
    Helmi Zakariah CEO (Asia Pacific), AIME Inc. USA
    AIME, Malaysia, Malaysia
  • Jin  Shun, MBA
    Jin Shun, MBA Head, Regulatory Affairs, APAC
    Sandoz, Singapore
  • Jing Ping  Yeo, PhD
    Jing Ping Yeo, PhD Director, Research Integrity, Compliance and Ethics
    Singapore Health Services Pte Ltd, Singapore
  • Kum Cheun  Wong, PharmD
    Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
    Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
  • Lars  Nelleman, MD, MPharm
    Lars Nelleman, MD, MPharm Vice President, Drug Development Satellite Singapore
    Lundbeck Singapore Pte. Ltd., Singapore
  • Vicky (Fengyun)  Han
    Vicky (Fengyun) Han Senior Director, Asia Pacific Regulatory Policy Lead, Janssen Asia Pacific
    Johnson & Johnson Pte. Ltd., Singapore
Load More

Contact us

Digital Learning Catalog

DIA Learning: 2018 eLearning Soultions
Download